[ibd-display-video id=2368044 width=50 float=left autostart=true] This exclusive rating from Investor's Business Daily measures share price performance with a 1 (worst) to 99 (best) score. The score shows how a stock's price performance over the last 52 weeks compares to all the other stocks in our database.
History shows that the market's biggest winners tend to have an RS Rating of over 80 as they launch their biggest climbs.
Halyard Health is in a buy zone after climbing above a 46.73 buy point in a flat base . Once a stock moves 5% or higher beyond the initial entry, it's considered out of a proper buy zone.
Top and bottom line growth moved higher in the company's most recent quarter. Earnings were up 25%, compared to 13% in the prior report. Revenue increased from 0% to 1%.
The company earns the No. 5 rank among its peers in the Medical-Supplies industry group. Becton Dickinson ( BDX ) is the top-ranked stock within the group.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.